Access Bio has ranked among the top searched stocks for 12 days in the past month.
As of 10:30 AM on the 21st, Access Bio is trading at 30,800 KRW, up 5.66% from the previous day. This marks a 35.09% increase compared to September 25. Access Bio is known as a specialized manufacturer of in vitro diagnostic products, including malaria diagnostic kits.
Over the past five days, individual investors have net purchased 40,412 shares, while foreigners and institutions have net sold 49,707 shares and net purchased 1,275 shares, respectively.
On October 13, Access Bio became a market issue with the headline "Surge following US approval of COVID-19 diagnostic kit."
※ Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an article automation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
